Mini-Orals

Sponsored by

Mini-Oral Video: Kidney
MO1.1 Decreased incidence of typical uremic hemolytic syndrome as a cause for kidney transplantation in children at Garrahan Hospital
Natalia Yanet Panero Schipper, Argentina
MO1.2 The Relationship between Mental Health Status and Social Life in Children and Adolescents with Kidney Transplantation
Hande Ayraler Taner, Turkey
MO1.4 Clinical characteristics of recurrent focal segmental glomerulosclerosis (rFSGS) after kidney transplant (KTx) through computable phenotypic algorithm analyses of multi-center data
Vikas Dharnidarka, United States
MO1.8 Early corticosteroid withdrawal is associated with improved adult height in pediatric kidney transplant recipients
Gilles Tourlamain, Belgium
Mini-Oral Video: Liver Clinical
MO2.2 A precision medicine approach to tacrolimus pharmacokinetics after pediatric living donor liver transplantation in an ethnically diverse population.
Jean Botha, South Africa
MO2.3 Pediatric liver transplant recipient factors that influence tacrolimus absorption
Mary M Chandran, United States
MO2.4 Clinical outcomes of children with microvillus inclusion disease: A single-center retrospective study in the United States
Emily G Dietle, United States
MO2.6 17 Years of Pediatric Liver Transplantation Experience for Cirrhosis and Hepatocellular Carcinoma
Figen Ozcay, Turkey
MO2.5 Quality improvement project to safely expedite liver biopsy in pediatric acute liver failure
Julianne Mendoza, United States
MO2.7 Quality of life, depression, anxiety and motivations in donor candidates for pediatric living donor liver transplantation
Joao Seda Neto, Brazil
MO2.8 Factors associated with thrombotic and hemorrhagic complications in pediatric liver transplantation: A multi-center analysis from the Starzl Network for Excellence in Pediatric Transplantation
Kyle A Soltys, United States
Mini-Oral Video: Liver Surgical
MO3.1 The impact of low recipient weight in the long-term outcomes in 1078 pediatric living donor liver transplants
Joao Seda Neto, Brazil
MO3.2 Normothermic Machine Perfusion in Pediatric Liver Transplantation: A Survey of Attitudes and Barriers
Yash Kadakia, United States
MO3.3 Therapeutic potential of living donor liver transplantation from heterozygous carrier donors in children with propionic acidemia
Guang-Peng Zhou, People's Republic of China
MO3.4 Liver Transplantation for Pediatric Hepatocellular Carcinoma: A Systematic Review of the Literature
Ioannis A. Ziogas, United States
MO3.5 Can non-directed living liver donation correct socioeconomic disparities inherent to pediatric living donor liver transplantation?
Dor Yoeli, United States
MO3.6 Post-operative complications in pediatric liver transplant recipients on heparin can be identified with Thrombelastography but not conventional assays.
Megan A Adams, United States
MO3.8 Liver nodules in biliary atresia patients
Ana M. Calinescu, Switzerland
Mini-Oral Video: Pot-Pourri
MO4.1 Clinical outcome after Renal Transplantation in Small Children < 15 kilos: 38 years of Dutch experience
Antonia Bouts, Netherlands
MO4.3 Electronic screening of mental health and adherence barriers in pediatric solid organ transplant patients
Kelli N Triplett PhD ABPP, United States
MO4.4 Kidney transplant adolescents - lost in transition? – A nationwide analysis 2000-2020
Ingvild A Kindem, Norway
MO4.5 Monitoring of EBV-specific immunity and humoral milieu factors as early markers for PTLD development in EBV positive high risk pediatric SOT patients - first results of the EB-VISI study
Rebecca E. Schultze-Florey, Germany
MO4.6 Concurrent cultured thymus tissue implantation and orthotopic heart transplantation: a case report on the first clinical experience
Lillian Kang, United States
MO4.7 Lung transplantation in a 2 year-old child from a controlled donation after circulatory death (DCD)
Ignacio Iglesias-Serrano, Spain
MO4.8 Implementation of a Psychological Screener in Pediatric Kidney and Heart Transplant Clinics
Gillian S Mayersohn, United States